TY - JOUR
T1 - Landscape and function of multiple mutations within individual oncogenes
AU - Saito, Yuki
AU - Koya, Junji
AU - Araki, Mitsugu
AU - Kogure, Yasunori
AU - Shingaki, Sumito
AU - Tabata, Mariko
AU - McClure, Marni B.
AU - Yoshifuji, Kota
AU - Matsumoto, Shigeyuki
AU - Isaka, Yuta
AU - Tanaka, Hiroko
AU - Kanai, Takanori
AU - Miyano, Satoru
AU - Shiraishi, Yuichi
AU - Okuno, Yasushi
AU - Kataoka, Keisuke
N1 - Funding Information:
Acknowledgements We acknowledge support from the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 17K19592,18K06594 and 15H05912) and National Cancer Center Research and Development Funds (30-A-1), together with many other funding bodies, organizations and individuals (see Supplementary Note).
Publisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2020/6/4
Y1 - 2020/6/4
N2 - Sporadic reports have described cancer cases in which multiple driver mutations (MMs) occur in the same oncogene1,2. However, the overall landscape and relevance of MMs remain elusive. Here we carried out a pan-cancer analysis of 60,954 cancer samples, and identified 14 pan-cancer and 6 cancer-type-specific oncogenes in which MMs occur more frequently than expected: 9% of samples with at least one mutation in these genes harboured MMs. In various oncogenes, MMs are preferentially present in cis and show markedly different mutational patterns compared with single mutations in terms of type (missense mutations versus in-frame indels), position and amino-acid substitution, suggesting a cis-acting effect on mutational selection. MMs show an overrepresentation of functionally weak, infrequent mutations, which confer enhanced oncogenicity in combination. Cells with MMs in the PIK3CA and NOTCH1 genes exhibit stronger dependencies on the mutated genes themselves, enhanced downstream signalling activation and/or greater sensitivity to inhibitory drugs than those with single mutations. Together oncogenic MMs are a relatively common driver event, providing the underlying mechanism for clonal selection of suboptimal mutations that are individually rare but collectively account for a substantial proportion of oncogenic mutations.
AB - Sporadic reports have described cancer cases in which multiple driver mutations (MMs) occur in the same oncogene1,2. However, the overall landscape and relevance of MMs remain elusive. Here we carried out a pan-cancer analysis of 60,954 cancer samples, and identified 14 pan-cancer and 6 cancer-type-specific oncogenes in which MMs occur more frequently than expected: 9% of samples with at least one mutation in these genes harboured MMs. In various oncogenes, MMs are preferentially present in cis and show markedly different mutational patterns compared with single mutations in terms of type (missense mutations versus in-frame indels), position and amino-acid substitution, suggesting a cis-acting effect on mutational selection. MMs show an overrepresentation of functionally weak, infrequent mutations, which confer enhanced oncogenicity in combination. Cells with MMs in the PIK3CA and NOTCH1 genes exhibit stronger dependencies on the mutated genes themselves, enhanced downstream signalling activation and/or greater sensitivity to inhibitory drugs than those with single mutations. Together oncogenic MMs are a relatively common driver event, providing the underlying mechanism for clonal selection of suboptimal mutations that are individually rare but collectively account for a substantial proportion of oncogenic mutations.
UR - http://www.scopus.com/inward/record.url?scp=85083052707&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083052707&partnerID=8YFLogxK
U2 - 10.1038/s41586-020-2175-2
DO - 10.1038/s41586-020-2175-2
M3 - Article
C2 - 32494066
AN - SCOPUS:85083052707
SN - 0028-0836
VL - 582
SP - 95
EP - 99
JO - Nature
JF - Nature
IS - 7810
ER -